Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Preemptive antiviral therapy with entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization

Sun Hong Yoo, Jeong Won Jang, Jung Hyun Kwon, Seung Min Jung, Bohyun Jang, Jong Young Choi

Clin Mol Hepatol. 2016;22(4):458-465. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0054

View: 9011 Download: 134 Web of Science: 10 Crossref: 10

Review

Acute kidney injury in liver cirrhosis: new definition and application

Florence Wong

Clin Mol Hepatol. 2016;22(4):415-422. Published online December 14, 2016

DOI: https://doi.org/10.3350/cmh.2016.0056

View: 14210 Download: 760 Web of Science: 55 Crossref: 59

Case Report

A Korean patient with Guillain-Barré syndrome following acute hepatitis E whose cholestasis resolved with steroid therapy

Sung Bok Ji, Sang Soo Lee, Hee cheul Jung, Hong Jun Kim, Hyun Jin Kim, Tae Hyo Kim, Woon Tae Jung, Ok Jae Lee, Dae Hyun Song

Clin Mol Hepatol. 2016;22(3):396-399. Published online August 30, 2016

DOI: https://doi.org/10.3350/cmh.2015.0039

View: 17220 Download: 117 Web of Science: 6 Crossref: 8

Original Article

Hepatitis B surface antigen titer is a good indicator of durable viral response after entecavir off-treatment for chronic hepatitis B

Han Ah Lee, Yeon Seok Seo, Seung Woon Park, Sang Jung Park, Tae Hyung Kim, Sang Jun Suh, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun, Soon Ho Um

Clin Mol Hepatol. 2016;22(3):382-389. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0047

View: 12268 Download: 201 Web of Science: 18 Crossref: 19

Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B

Jaemin Lee, Sun Hong Yoo, Won Sohn, Hyung Woo Kim, Yong Sun Choi, Jung Ho Won, Jin Young Heo, Sang Jong Park, Young Min Park

Clin Mol Hepatol. 2016;22(3):339-349. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0021

View: 11855 Download: 164 Web of Science: 19 Crossref: 19

Review

Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment

Hyunwoo Oh, Dae Won Jun, Waqar K Saeed, Mindie H Nguyen

Clin Mol Hepatol. 2016;22(3):327-335. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0049

View: 15699 Download: 534 Web of Science: 51 Crossref: 51

Editorial

Is the tenofovir based therapy almighty for previous treatment failure in chronic hepatitis B?

Hyung Joon Yim

Clin Mol Hepatol. 2016;22(2):238-240. Published online June 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0103

View: 8406 Download: 96 Web of Science: 1 Crossref: 1

Review

KASL clinical practice guidelines: Management of Hepatitis C

The Korean Association for the Study of the Liver (KASL)

Clin Mol Hepatol. 2014;20(2):89-136. Published online June 30, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.2.89

View: 25387 Download: 90 Web of Science: 25 Crossref: 30

Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade

Hyung Joon Yim, Seong Gyu Hwang

Clin Mol Hepatol. 2013;19(3):195-209. Published online September 30, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.3.195

View: 11734 Download: 71 Crossref: 24

Original Article

Clinical and epidemiological characteristics of Korean patients with hepatitis C virus genotype 6

Mun Hyuk Seong, Ho Kil, Jong Yeop Kim, Sang Soo Lee, Eun Sun Jang, Jin-Wook Kim, Sook-Hyang Jeong, Young Seok Kim, Si Hyun Bae, Youn Jae Lee, Han Chu Lee, Haesun Yun, Byung Hak Kang, Kisang Kim

Clin Mol Hepatol. 2013;19(1):45-50. Published online March 25, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.1.45

View: 7692 Download: 91 Crossref: 12

Clinical impacts of hazardous alcohol use and obesity on the outcome of entecavir therapy in treatment-naïve patients with chronic hepatitis B infection

Won Gil Chung, Hong Joo Kim, Young Gil Choe, Hyo Sun Seok, Chang Wook Chon, Yong Kyun Cho, Byung Ik Kim, Young Yool Koh

Clin Mol Hepatol. 2012;18(2):195-202. Published online June 26, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.2.195

View: 9319 Download: 71 Crossref: 12

High efficacy of adefovir and entecavir combination therapy in patients with nucleoside-refractory hepatitis B

Hee Bok Chae, Mee Jin Kim, Eui Geun Seo, Yong Hyeok Choi, Hee Seung Lee, Joung Ho Han, Soon Man Yoon, Seon Mee Park, Sei Jin Youn

Clin Mol Hepatol. 2012;18(1):75-83. Published online March 22, 2012

DOI: https://doi.org/10.3350/kjhep.2012.18.1.75

View: 7402 Download: 45 Crossref: 12

Analysis of prognostic factors and 5-year survival rate in patients with hepatocellular carcinoma: a single-center experience

Sang Seok Lee, Hyun Sung Shin, Hyung Joon Kim, Su Jin Lee, Hyun Suk Lee, Kyung Hee Hyun, Yong Hyun Kim, Byoung Woon Kwon, Jin Hyung Han, Hoon Choi, Bae Hwan Kim, Joon Hyuk Lee, Ha Yan Kang, Hyun Deok Shin, Il Han Song

Clin Mol Hepatol. 2012;18(1):48-55. Published online March 22, 2012

DOI: https://doi.org/10.3350/kjhep.2012.18.1.48

View: 8295 Download: 53 Crossref: 32

Applicability of the BCLC staging system to patients with hepatocellular carcinoma in Korea: analysis at a single center with a liver transplant center

Sung Eun Kim, Han Chu Lee, Kang Mo Kim, Young-Suk Lim, Young-Hwa Chung, Yung Sang Lee, Dong Jin Suh

Clin Mol Hepatol. 2011;17(2):113-119. Published online June 23, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.2.113

View: 8678 Download: 49 Crossref: 25

Review

New treatments for chronic hepatitis C

Jae Young Jang, Raymond T. Chung

Clin Mol Hepatol. 2010;16(3):263-277. Published online September 30, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.3.263

View: 8290 Download: 45 Crossref: 14

3

Mutations within the interferon sensitivity determining region in Korean patients infected with hepatitis C virus genotype 1b

Young-Joo Jin, M.D., Yoon Kyung Park, M.D., Gui Jun Yun, M.D. Han Chu Lee, M.D., Sook-Hyang Jeong, M.D. Gang Mo Kim, M.D., Young-Suk Lim, M.D., Young-Hwa Chung, M.D., Yung Sang Lee, M.D., Dong Jin Suh, M.D.

Clin Mol Hepatol. 2010;16(2):158-167. Published online June 25, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.2.158

View: 4286 Download: 23

Efficacy and predictors of the virologic response to entecavir therapy in nucleoside naive patients with chronic hepatitis B

Hyung-Joon Myung, M.D., Sook-Hyang Jeong, M.D., Jin-Wook Kim, M.D., Hee-Sup Kim, M.D., Je-Hyuck Jang, M.D., Dong Ho Lee, M.D., Nayoung Kim, M.D., Jin-Hyeok Hwang, M.D., Young Soo Park, M.D., Sang-Hyub Lee, M.D.

Clin Mol Hepatol. 2010;16(1):57-65. Published online March 26, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.1.57

View: 5465 Download: 31 Crossref: 9

Clinical efficacy of entecavir therapy and factors associated with treatment response in naive chronic hepatitis B patients

Myoung Hee Lee , Sun Gyo Lim , Su Jin Jeon , Chang Joon Kang , Young Ju Cho , Soon Sun Kim , Da Mi Lee , Jae Youn Cheong , Sung Won Cho

Clin Mol Hepatol. 2009;15(4):446-453. Published online December 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.4.446

View: 4537 Download: 27 Crossref: 4

Analysis of the cost-effectiveness of antiviral therapies in chronic hepatitis B patients in Korea

Byung Kook Kim, M.D., So Young Kwon, M.D., Chang Hong Lee, M.D., Won Hyeok Choe, M.D., Hong Mi Choi, M.S. Hye Won Koo, M.D.

Clin Mol Hepatol. 2009;15(1):25-41. Published online March 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.1.25

View: 5284 Download: 55 Crossref: 3

Clinical outcomes of systemic chemotherapy in hepatocellular carcinoma patients with multiple Lung metastases

Ki Tae Yoon, M.D. Jong Won Choi, M.D. Jun Yong Park, M.D. Sang Hoon Ahn, M.D., Ph.D. Yong Han Paik, M.D., Ph.D. Kwan Sik Lee, M.D., Ph.D. Kwang Hyub Han, M.D. Chae Yoon Chon, M.D. Do Young Kim, M.D.

Clin Mol Hepatol. 2008;14(3):360-370. Published online September 30, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.3.360

View: 4669 Download: 21 Crossref: 5

Comparison of therapeutic results between combination therapy of peginterferon alpha-2a plus ribavirin and interferon alpha-2b plus ribavirin according to treatment duration in patients with chronic hepatitis C

Heon Ju Lee , Jong Ryul Eun , Jae Won Choi , Kyung Ok Kim , Hee Jung Moon

Clin Mol Hepatol. 2008;14(1):46-57. Published online March 20, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.1.46

View: 4616 Download: 20 Crossref: 15

2

Nonalcoholic steatohepatitis: Pathogenesis and treatment

Sang Hoon Park

Clin Mol Hepatol. 2008;14(1):12-27. Published online March 20, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.1.12

View: 7029 Download: 106 Crossref: 5

Recent developments in systemic chemotherapy for hepatocellular carcinoma

Chul Ju Han

Clin Mol Hepatol. 2008;14(1):4-11. Published online March 20, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.1.4

View: 4514 Download: 36 Crossref: 1

3

Clinical Outcome after Living Donor Liver Transplantation in Patients with Hepatitis C Virus-associated Cirrhosis

Jeong-Ik Park, M.D. Kun-Moo Choi, M.D. Sung-Gyu Lee, M.D. Shin Hwang, M.D. Ki-Hun Kim, M.D. Chul-Soo Ahn, M.D. Deok-Bog Moon, M.D. Young-Hwa Chung, M.D. Yung-Sang Lee, M.D. Dong-Jin Suh, M.D.

Clin Mol Hepatol. 2007;13(4):543-555. Published online December 20, 2007

DOI: https://doi.org/10.3350/kjhep.2007.13.4.543

View: 4792 Download: 17 Crossref: 2

Five-year Survival Analysis of a Cohort of Hepatocellular Carcinoma Patients Who Treated at the National Cancer Center, Korea

Kyung Woo Park, M.D. Joong-Won Park, M.D., Tae Hyun Kim, M.D., Jun Il Choi, M.D., Seong Hoon Kim, M.D., Hong Suk Park, M.D., Sang Jae Park, M.D., Woo Jin Lee, M.D., Hae Lim Shin, M.D. and Chang-Min Kim, M.D.

Clin Mol Hepatol. 2007;13(4):530-543. Published online December 20, 2007

DOI: https://doi.org/10.3350/kjhep.2007.13.4.530

View: 5447 Download: 47 Crossref: 11

The Efficacy and Safety of Telbivudine in Korean Patients with Chronic Hepatitis B

Young-Myoung Moon, M.D. Seong-Gyu Hwang, M.D. Boo-Sung Kim, M.D. Kyu-Sung Rim, M.D. Mong Cho, M.D. Dong-Joon Kim, M.D. Joon-Yeol Han, M.D. Young-Seok Kim, M.D. Ho-Soon Choi, M.D. Sang-Hoon Ahn, M.D.

Clin Mol Hepatol. 2007;13(4):503-512. Published online December 20, 2007

DOI: https://doi.org/10.3350/kjhep.2007.13.4.503

View: 4570 Download: 29 Crossref: 6

1

Review: Clinical Outcome after Living Donor Liver Transplantation in Patients with Hepatitis C Virus-associated Cirrhosis

Hyung Joon Kim

Clin Mol Hepatol. 2007;13(4):489-494. Published online December 20, 2007

DOI: https://doi.org/10.3350/kjhep.2007.13.4.489

View: 3726 Download: 17

3

Clinical Features and Treatment Outcome of Advanced Hepatocellular Carcinoma with Inferior vena Caval Invasion or Atrial Tumor Thrombus

Seung Up Kim, M.D. Yu Ri Kim, M.D. Do Young Kim, M.D. Ja Kyung Kim, M.D. Hyun Woong Lee, M.D. Beom Kyung Kim, M.D. Kwang Hyub Han, M.D. Chae Yoon Chon, M.D. Young Myoung Moon, M.D. Sang Hoon Ahn, M.D.

Clin Mol Hepatol. 2007;13(3):387-395. Published online September 20, 2007

DOI: https://doi.org/10.3350/kjhep.2007.13.3.387

View: 5413 Download: 69 Crossref: 9

Efficacy of Transarterial Chemolipiodolization with or without 3-Dimensional Conformal Radiotherapy for Huge HCC with Portal Tumor Thrombosis

Chan Ran You, M.D., Jeong Won Jang, M.D., Seok Hui Kang, M.D., Si Hyun Bae, M.D., Jong Young Choi, M.D., Seung Kew Yoon, M.D., Ihl Bhong Choi, M.D. Dong Hoon Lee, M.D. Ho Jong Chun, M.D. Byung Gil Choi, M.D.

Clin Mol Hepatol. 2007;13(3):378-386. Published online September 20, 2007

DOI: https://doi.org/10.3350/kjhep.2007.13.3.378

View: 4930 Download: 54 Crossref: 13

Short-term Therapy with Pegylated Interferon plus Ribavirin for the Chronic Hepatitis C Genotype 2 Patients

Eun Uk Jung , Ji Hun Park , Kyung Im Pae , Suk Woo Kang , Sung Jae Park , Sam Ryong Jee , Eun Tak Park , Youn Jae Lee , Sang Hyuk Lee , Sang Young Seol

Clin Mol Hepatol. 2007;13(3):341-348. Published online September 20, 2007

DOI: https://doi.org/10.3350/kjhep.2007.13.3.341

View: 3962 Download: 21 Crossref: 2

1 | 2 | 3 |

Viewed By 5505	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5405	MAFLD: How is it different from NAFLD?
Viewed By 5214	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 5094	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4725	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 176	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 113	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 108	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 90	MAFLD: How is it different from NAFLD?
Cited By 80	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search